Guidance for Industry on Fees for Human Drug Compounding Outsourcing Facilities Under Sections 503B and 744K of the Federal Food, Drug, and Cosmetic Act
OMB: 0910-0776
IC ID: 212978
⚠️ Notice: This information collection may be referencing outdated material. More recent filings for OMB 0910-0776 can be found here: